Cresco Labs (XCNQ:CL) Accounts Payable & Accrued Expense : C$240 Mil (As of Dec. 2023)

View and export this data going back to 1991. Start your Free Trial

What is Cresco Labs Accounts Payable & Accrued Expense?

Cresco Labs's quarterly accounts payable & accrued expense increased from Jun. 2023 (C$253 Mil) to Sep. 2023 (C$280 Mil) but then declined from Sep. 2023 (C$280 Mil) to Dec. 2023 (C$240 Mil).

Cresco Labs's annual accounts payable & accrued expense increased from Dec. 2021 (C$224 Mil) to Dec. 2022 (C$256 Mil) but then declined from Dec. 2022 (C$256 Mil) to Dec. 2023 (C$240 Mil).

Cresco Labs Accounts Payable & Accrued Expense Historical Data

The historical data trend for Cresco Labs's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs Accounts Payable & Accrued Expense Chart

Cresco Labs Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

121.14

243.07

223.58

255.53

240.16

Cresco Labs Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															255.53	242.23	253.50	279.70	240.16

Cresco Labs Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Cresco Labs (XCNQ:CL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (XCNQ:CL) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

CRLBF:USA 6CQ:Germany

Address

400 W. Erie Street, Suite 110, Chicago, IL, USA, 60654

Website

https://www.crescolabs.com

Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and third-party retail stores. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.